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proliferated beyond 5th and 6th cell-divisions respectively, whereas
the lovastatin treatment reduced the number to 31% and 48%
respectively. In summary, we demonstrated here that lovastatin
prevents both homing and proliferating of donor-derived T cells in
the secondary lymphoid organs, which are crucial sites for allo-
reactive expansion. While most of the control mice died of acute
GVHD within the ﬁrst week of post-transplant when alloreactive
T cells inﬁltrated the targeted organs, lovastatin treatment pre-
vented the activation and expansion of donor-derived T cells, and
thus reduced the GVHD mortality and morbidity. Our study
provides rationale for a potential novel treatment for GVHD.
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The role of the IFN-g in the development of GVHD is enig-
matic due to an abundance of partially contradicting results.
Whereas there is evidence that GVHD can occur in the absence of
IFN-g, it has been demonstrated in preclinical BMT models that
IFN-g may accelerate or mitigate GVHD depending on the ex-
perimental setting. We have focused on the role of STAT1 in the
development of GVHD, the major signaling pathway of IFN-g.
We studied STAT1 and p-STAT1 (Tyr701) expression by immu-
nohistochemistry in the GVHD target organs liver, small bowel
and colon following induction of GVHD and correlated these
ﬁndings with the presence of lamina propria (LP) lymphocytes,
typical features of GVHD-induced tissue damage and expression of
tissue cytokines/chemokines. GVHD was induced in the fully
MHC mismatched BALB/c to B6 strain combination following
lethal irradiation with 975 rad. As detected by western blots p-
STAT1 expression became detectable on day 1 in the spleen and
on days 3 in the liver, small bowel and colon. Compared to
untreated controls immunohistochemical p-STAT1 staining be-
came apparent on day 3 post-BMT in the small bowel and colon
of syngeneic controls and GVHD animals. Whereas p-STAT1
expression was only transient in syngeneic controls, a further in-
crease in p-STAT1 staining was observed in GVHD animals in the
colon and small bowel on day 6. In the colon this signiﬁcant
increase in crypt cell p-STAT1 staining was associated with the
presence of LP inﬁltrating lymphocytes and coincided with the
maximal features of tissue damage (luminal sloughing, crypt de-
struction and crypt apoptosis). In line with these results IFN-g
protein expression became detectable in colon tissue lysates on day
6 supporting the role of IFN-g producing inﬁltrating donor T
cells in causing STAT1 activation and tissue damage. We conclude
that in comparison to untreated controls STAT1 activation can be
observed in the colon and small bowel starting on day 3 in
animals with GVHD and syngeneic controls. Whereas pSTAT1
staining peaks at day 3 in syngeneic controls and declines there-
after, maximal STAT1 activation occurs in GVHD animals on day
6 , coincides with detectable IFN-g expression and is accompa-
nied by LP inﬁltration and features of severe GVHD-related tissue
damage. To fully understand the role of IFN-g in the development
of gut GVHD further studies are warranted to delineate the role of
STAT1 dependent and independent signaling pathways in the
development of GVHD.
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Purpose: To test the hypothesis that global gene expression
proﬁles of peripheral blood mononuclear cells (PBMNC) day 14
after hematopoietic cell transplantation (HCT) with nonmyeloab-
lative conditioning could predict the later occurrence of acute
graft-versus-host disease (aGVHD) grade II-IV.Material:Ninety-
eight patients with hematological malignancies received HCT with
peripheral blood stem cells from an HLA-identical sibling/mother
donor (N64/1) or from a matched unrelated donor (N33)
following nonmyeloablative conditioning with low dose ﬂudara-
bine and 2 Gy of total body irradiation. Post-transplant immuno-
suppression consisted of cyclosporine and mycophenolate mofetil.
Among these patients, 16 patients never experiencing aGVHD and
16 patients experiencing aGVHD grade II-IV before day 70
(range 21-70) were selected.Methods: RNA was precipitated from
frozen PBMNC from day 14 post-transplant and gene proﬁling
analyses were performed using Human Genome U133 Plus 2.0
GeneChip Array. The array data were normalized and GCMA
modelled in R, log2 transformed, corrected for batch variation, and
subsequently imported into dChip for further analysis. Results:
The diffentially regulated gene expression between the two groups
was identiﬁed and formed the basis for the subsequent principal
component analysis. This separated more than 85% of patients
who experienced aGvHD from those who did not. Conclusion:
Albeit preliminary, these data suggest that pattern of gene expres-
sion proﬁles early post-transplant seems to be able to predict
patients with high risk of later occurrence of aGVHD from those
never experiencing aGVHD in this retrospective study. This
knowledge could be exploited to increase the immunosupression
and thus prevent aGVHD in patients at risk. Furthermore, this
method could help identify candidate genes of interest for the
pathogenesis of aGVHD.
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Dendritic cells (DC) are antigen-presenting cells involved in
induction and regulation of immune responses. We investigated
the impact of the number of infused and engrafted (day 28) den-
dritic cells, DC1 (lin-HLA-DRCD11c) and DC2 (lin-HLA-
DRCD123), on the development of acute and chronic GVHD.
68 patients who underwent HLA matched related G-CSF mobi-
lized allogeneic PBSCT were included in the analysis. The median
age was 28 years (range: 3-55) and there were 43 (63%) males.
Conditioning regimen was myeloablative in 34 (Bu/Cy20; Cy/
TBI  14) and reduced intensity in the rest (Flu/Mel 12; Flu/Cy
15; Flu/Cy/ATG 3; Flu/Bu/Cy1; Flu1; Ida/Flu/Cyto-
sine2). All patients received cyclosporine and short course meth-
otrexate as GVHD prophylaxis. 23 patients developed acute
GVHD (grade II-IV) and 21 patients had chronic GVHD. Twelve
patients received steroids before day 28 for treatment of GVHD.
Seven patients died before day 28 and were excluded from the
analysis; 2 of these patients had acute GVHD. On a univariate
analysis day-28 total DC, DC1 and DC2 were signiﬁcantly asso-
ciated with development of acute and chronic GVHD while graft
total DC, DC1 and DC2 did not show a similar association. Using
a ROC curve plot analysis, cutoff values for day-28 DC (Total
DC10.7/ul, DC19.7/ul and DC2  4.5/ul) gave the highest
likelihood ratios for acute GVHD (2.77, 2.14and 3.29 respec-
tively). These cut off values signiﬁcantly discriminated patients
probability of developing acute and chronic GVHD on a univariate
analysis. On a multivariate analysis, a low day-28 DC2 (4.5/ul)
together with patient age retained their risk for acute GVHD
(HR67.74 and 1.05, P-values 0.000 and 0.042 respectively), while
for chronic GVHD only a low day-28 DC2 remained signiﬁcant
(HR12.8, P0.005). Using the DC2 cutoff value of 4.5/ul, pa-
tients were categorized into a high ( 4.5/ul) (n31) and a low
DC2 (4.5/ul) (n30) group. These two groups were comparable
with regard to age, sex, FM, conditioning regimen and graft
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